{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T23:09:08Z","timestamp":1773356948834,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.clinthera.2014.01.004","type":"journal-article","created":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T23:04:41Z","timestamp":1392332681000},"page":"273-279","source":"Crossref","is-referenced-by-count":7,"title":["Pharmacokinetic Properties and Bioequivalence of 2 Formulations of Valsartan 160-mg Tablets: A Randomized, Single-Dose, 2-Period Crossover Study in Healthy Korean Male Volunteers"],"prefix":"10.1016","volume":"36","author":[{"given":"Ji-Eon","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Hyo","family":"Ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Soo","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Jong","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ree-Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geun","family":"Tae Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae-Duk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2014.01.004_bib1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1476-5381.1993.tb13877.x","article-title":"Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype","volume":"110","author":"Criscione","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clinthera.2014.01.004_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3797\/scipharm.1009-01","article-title":"Formulation and bioequivalence of two valsartan tablets after a single oral administration","volume":"79","author":"Zaid","year":"2011","journal-title":"Sci Pharm"},{"key":"10.1016\/j.clinthera.2014.01.004_bib3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijpharm.2012.05.076","article-title":"Enhanced oral bioavailability of novel mucoadhesive pellets containing valsartan prepared by a dry powder-coating technique","volume":"434","author":"Cao","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.clinthera.2014.01.004_bib4","first-page":"185","article-title":"Bioavailability file: valsartan","volume":"32","author":"Saydam","year":"2007","journal-title":"FABAD J Pharm Sci"},{"key":"10.1016\/j.clinthera.2014.01.004_bib5","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1248\/cpb.38.3112","article-title":"Gastric acidity-dependent bioavailability of commercial sustained release preparations of indomethacin, evaluated by gastric acidity-controlled beagle dogs","volume":"38","author":"Yamada","year":"1990","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1016\/j.clinthera.2014.01.004_bib6","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s12272-010-0814-0","article-title":"Improved pH-independent dissolution and oral absorption of valsartan via the preparation of solid dispersion","volume":"33","author":"Park","year":"2010","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.clinthera.2014.01.004_bib7","unstructured":"Korean Food and Drug Administration (KFDA). Guideline for management of bioequivalence test [KFDA notification no. 2012-103]. http:\/\/www.mfds.go.kr\/index.do?mid=95&pageNo=12&seq=5577&cmd=v. Accessed January 11, 2013."},{"key":"10.1016\/j.clinthera.2014.01.004_bib8","first-page":"217","article-title":"One-step sample size determination for 2x2 bioequivalence study","volume":"39","author":"Lee","year":"2009","journal-title":"J Kor Pharm Sci"},{"key":"10.1016\/j.clinthera.2014.01.004_bib9","unstructured":"World Medical Association. Declaration of Helsinki: Ethical principles for medical research involving human subjects. As amended by the 59th WMA General Assembly, Seoul, October 2008. http:\/\/www.wma.net\/en\/30publications\/10policies\/b3\/17c.pdf. Accessed January 11, 2013."},{"key":"10.1016\/j.clinthera.2014.01.004_bib10","first-page":"308","article-title":"Analysis of bioequivalence study using log-transformed model","volume":"44","author":"Lee","year":"2000","journal-title":"Yakhakhoeji"},{"key":"10.1016\/j.clinthera.2014.01.004_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0168-3659(02)00490-X","article-title":"Development and validation of an in vitro-in vivo correlation for buspirone hydrochloride extended release tablets","volume":"88","author":"Takka","year":"2003","journal-title":"J Control Release"},{"key":"10.1016\/j.clinthera.2014.01.004_bib12","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.clinthera.2010.03.004","article-title":"Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a single-dose randomized, open-label, three-period crossover comparison in healthy Indian male volunteers","volume":"32","author":"Iqbal","year":"2010","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2014.01.004_bib13","first-page":"223","article-title":"Development of K-BE test, a computer program for the analysis of bioequivalence","volume":"28","author":"Lee","year":"1998","journal-title":"J Kor Pharm Sci"},{"key":"10.1016\/j.clinthera.2014.01.004_bib14","series-title":"Guideline for the Validation of Bioanalytical Method","year":"2010"},{"key":"10.1016\/j.clinthera.2014.01.004_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0928-0987(96)00256-4","article-title":"Improvement of dissolution of poorly soluble drugs by solid deposition on a super disintegrant. II. The choice of super disintegrants and effect of granulation","volume":"5","author":"Bolhuis","year":"1997","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.clinthera.2014.01.004_bib16","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.clinthera.2009.09.002","article-title":"Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions","volume":"31","author":"Sp\u00ednola","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2014.01.004_bib17","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.clinthera.2013.04.014","article-title":"Pharmacokinetic interactions of valsartan and hydrochlorothiazide: an open-label, randomized, 4-period crossover study in healthy Egyptian male volunteers","volume":"35","author":"Hedaya","year":"2013","journal-title":"Clin Ther"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814000125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814000125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T17:51:00Z","timestamp":1538848260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291814000125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0149291814000125"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2014.01.004","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}